Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases

Rheumatology International

Volumn 34, Issue 3, 2014, Pages 393-399

  Chrostek, Lech ^a   Cylwik, Bogdan ^a   Gindzienska Sieskiewicz, Ewa ^a   Gruszewska, Ewa ^a   Szmitkowski, Maciej ^a   Sierakowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Glycosylation abnormalities; Rheumatic diseases; Sialic acid

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; GLYCOPROTEIN; SIALIC ACID;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VERY ELDERLY;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; HAPTOGLOBINS; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; SCLERODERMA, SYSTEMIC;

EID: 84896706008     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2921-y     Document Type: Article

References (29)

1. Raghav SK, Gupta B, Agrawal C, Saroha A, Das RH, Chaturvedi VP, Das HR (2006) Altered expression and glycosylation of plasma proteins in rheumatoid arthritis. Glycoconj J 23:167-173
2. Axford JS (1999) Glycosylation and rheumatic disease. Biochim Biophys Acta 1455:219-229
3. Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670-673
4. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320:373-376. doi: 10.1126/science.1154315
5. Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS (2007) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524-1534
6. Nimmerjahn F, Anthony RM, Ravetch JV (2007) Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 104:8433-8437
7. Przybysz M, Maszczak D, Borysewicz K, Szechinski J, Katnik-Prastowska I (2007) Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis. Glycoconj J 24:543-550
8. Feelders RA, Vreugdenhil G, de Jong G, Swaak AJG, van Eijk HG (1992) Transferrin microheterogeneity in rheumatoid arthritis. Rheumatol Int 12:195-199
9. Saroha A, Biswas S, Chatterjee BP, Das HR (2011) Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis. J Chromatogr B Analyt Technol Biomed Life Sci 879:1839-1843. doi: 10.1016/j.jchromb.2011.04.024
10. Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M (2010) Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Adv Med Sci 55:80-85. doi: 10.2478/v10039-010-0006-7
11. Paul R, Rotzsch W (1989) The diagnostic significance of mucoproteins, sialic acid and cortisol in assessing the activity of rheumatic diseases. Z Gesamte Inn Med 44:410-413
12. Alturfan AA, Uslu EU, Alturfan EE, Hatemi G, Fresko I, Kokoglu E (2007) Increased serum sialic acid levels in primary osteoarthritis and inactive rheumatoid arthritis. Tohoku J Exp Med 213:241-248
13. Skoza L, Mohos S (1976) Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assays in analytical De-O-acetylation. Biochem J 159:457-462
14. Gornik O, Lauc G (2008) Glycosylation of serum proteins in inflammatory diseases. Dis Markers 25:267-278
15. Pasek M, Duk M, Podbielska M, Sokolik R, Szechinski J, Lisowska E, Krotkiewski H (2006) Galactosylation of IgG from rheumatoid arthritis (RA) patients: changes during therapy. Glycoconj J 23:463-471
16. Gornik I, Maravic G, Dumic J, Flogel M, Lauc G (1999) Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem 32:605-608
17. Matsumoto A, Shikata K, Takeuchi F, Kojima N, Mizuochi T (2000) Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem 128:621-628
18. Maury CP, Helve T, Sjöblom C (1982) Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus. Rheumatol Int 2:145-149
19. Ota T, Uemura A, Eto S, Suzuki H (1985) Clinical significance of serum sialic acid in rheumatoid arthritis and systemic lupus erythematosus. J Uoeh 7:401-407
20. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
21. Ansar W, Ghosh S (2013) C-reactive protein and the biology of disease. Immunol Res 561:131-142. doi: 10.1007/s12026-013-8384-0
22. Silva I, Mateus M, Branco JC (2010) Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction. Acta Rheumatol Port 35:456-462
23. Pepys MB, Lanham JG, De Beer FC (1982) C-reactive protein in SLE. Clin Rheum Dis 8:91-103
24. Bell SA, Faust H, Schmid A, Meurer M (1998) Autoantibodies to C-reactive protein and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol 113:327-332
25. Kovacs A, Green F, Hansson LO, Lundman P, Samnegard A, Boquist S, Ericsson CG, Watkins H, Hamsten A, Tornvall P (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178:193-198
26. Muangchan C, Harding S, Khimdas S, Bonner A, The Canadian Scleroderma Research Group, Baron M, Pope J (2012) Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian scleroderma research group. Arthritis Care Res 64:1405-1414. doi: 10.1002/acr.21716
27. Ceciliani F, Pocacqua V (2007) The acute phase protein α1-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Peptide Sci 8:91-108
28. Treuheit MJ, Halsall HB (1992) Disease-coupled specificity in the glycan structures of orosomucoid. Clin Chim Acta 210:237-239
29. De Graaf TW, Van der Stelt ME, Anbergen MG, van Dijk W (1993) Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177:657-666